• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 3. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 4. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Professional Introduction to (2-chloro-4-pyridyl)-cycloheptyl-methanone (CAS No. 898785-24-5)

(2-chloro-4-pyridyl)-cycloheptyl-methanone is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and functional properties. This compound, identified by the CAS number 898785-24-5, has garnered attention due to its potential applications in drug discovery and development. The molecular structure of this compound consists of a cycloheptyl group linked to a methanone moiety, with a pyridine ring substituted at the 2-position with a chlorine atom at the 4-position. Such structural features make it a versatile scaffold for designing novel bioactive molecules.

The< strong>pyridine moiety is a key pharmacophore in many pharmaceutical agents, known for its ability to interact with biological targets such as enzymes and receptors. The presence of a chlorine atom at the 4-position of the pyridine ring enhances the electrophilicity of the molecule, making it more reactive in various chemical transformations. These properties are particularly valuable in medicinal chemistry, where modifications at specific positions can lead to improved pharmacological activity.

The< strong>cycloheptyl group contributes to the lipophilicity of the compound, which is often crucial for membrane permeability and bioavailability. This feature makes (2-chloro-4-pyridyl)-cycloheptyl-methanone a promising candidate for further investigation in developing drugs that require efficient absorption and distribution within the body. Additionally, the methanone functionality provides a site for further derivatization, allowing chemists to explore a wide range of analogs with tailored properties.

Recent advancements in computational chemistry have enabled more efficient screening of compounds like (2-chloro-4-pyridyl)-cycloheptyl-methanone for potential biological activity. Molecular docking studies have shown that this compound can interact with various targets, including enzymes involved in inflammatory pathways and metabolic processes. These interactions suggest that it may have therapeutic potential in conditions such as cancer, inflammation, and metabolic disorders.

In vitro studies have begun to elucidate the mechanism of action of (2-chloro-4-pyridyl)-cycloheptyl-methanone. Initial findings indicate that it may inhibit specific enzymes by binding to their active sites, thereby modulating biological pathways. For instance, research has hinted at its ability to suppress the activity of kinases, which are often overactive in cancer cells. This aligns with current trends in oncology research, where targeting kinases has become a cornerstone strategy for developing effective anti-cancer therapies.

The synthesis of (2-chloro-4-pyridyl)-cycloheptyl-methanone involves multi-step organic reactions, requiring careful optimization to ensure high yield and purity. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions and transition-metal-catalyzed hydrogenations, have been employed to construct the complex framework of this molecule. These methods not only enhance efficiency but also allow for greater control over regioselectivity and stereochemistry.

The< strong>CAS number 898785-24-5 serves as a unique identifier for this compound, facilitating its tracking and documentation in scientific literature and databases. This standardized numbering system ensures that researchers worldwide can accurately reference and utilize this compound in their studies. As more research emerges on (2-chloro-4-pyridyl)-cycloheptyl-methanone, its significance in pharmaceutical development is likely to grow.

The potential applications of this compound extend beyond oncology. Preliminary data suggest that it may also have antimicrobial properties, making it relevant in the fight against drug-resistant bacteria. The growing crisis of antibiotic resistance underscores the need for novel therapeutic agents like (2-chloro-4-pyridyl)-cycloheptyl-methanone, which could help address this global health challenge.

Future research directions include exploring derivatives of (2-chloro-4-pyridyl)-cycloheptyl-methanone with enhanced potency and selectivity. By modifying various functional groups within the molecule, scientists can fine-tune its pharmacological profile to maximize therapeutic benefit while minimizing side effects. Collaborative efforts between synthetic chemists and biologists will be essential in translating these findings into clinical applications.

In conclusion, (2-chloro-4-pyridyl)-cycloheptyl-methanone (CAS No. 898785-24-5) represents a promising area of investigation in pharmaceutical chemistry. Its unique structural features and potential biological activities make it an attractive candidate for further study and development. As research continues to uncover new applications for this compound, it holds significant promise for contributing to advancements in medicine and healthcare.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)